|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00000530 |
|
Date of registration:
|
27/10/1999 |
|
Primary sponsor: |
|
|
Public title:
|
Raynaud's Treatment Study (RTS)
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
September 1992 |
|
Target sample size:
|
|
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00000530 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Primary Purpose: Treatment
|
|
|
Contacts
|
|
Name:
|
Bruce Thompson |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Clinical Trials and Surveys Corporation |
| | |
|
Key inclusion & exclusion criteria
|
Men and women with documented primary or secondary Raynaud's syndrome.
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Cardiovascular Diseases
|
|
Heart Diseases
|
|
Raynaud's Disease
|
|
Vascular Diseases
|
|
Intervention(s)
|
|
Behavioral: biofeedback (psychology)
|
|
Drug: nifedipine
|
|
Procedure: electromyography
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|